Immune checkpoint inhibitors and mTOR inhibitors are known to be associated with skin toxicity…

VIENNA, Austria, is a city with unquestionable spirit, influence, and grandiosity, and would have been a spectacular host to this year’s European Academy of Dermatology and Venereology (EADV) 29th Congress…

Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…

Cutaneous ulceration presents many challenges to the dermatologist and multidisciplinary team due to a broad differential diagnosis, difficult management decisions, and delayed wound healing…

The unpredictability and fear of potentially life-threatening allergic reactions influences the occurrence and manifestation of anxiety in patients with severe drug allergy, as well as their family members…

The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…

A high number of benign melanocytic nevi has been implicated as a major risk factor for melanoma development;1 however, there are sparse data on the total body nevus count (TBNC) and its relation to the propensity for multiple primary melanomas…

Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…

I became involved in dermatology for various reasons, but what really attracted me was the impressive range and diversity of the specialty…